Susquehanna International Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.91M Buy
14,500
+12,300
+559% +$2.54M ﹤0.01% 5325
2025
Q4
$454K Sell
2,200
-16,600
-88% -$3.32M ﹤0.01% 9019
2025
Q3
$3.37M Buy
18,800
+3,900
+26% +$664K ﹤0.01% 4752
2025
Q2
$2.4M Buy
14,900
+3,300
+28% +$526K ﹤0.01% 5396
2025
Q1
$1.97M Buy
11,600
+9,200
+383% +$1.6M ﹤0.01% 5580
2024
Q4
$399K Sell
2,400
-20,400
-89% -$3.49M ﹤0.01% 9223
2024
Q3
$3.92M Buy
22,800
+7,400
+48% +$1.22M ﹤0.01% 4035
2024
Q2
$2.37M Buy
15,400
+1,200
+8% +$180K ﹤0.01% 4755
2024
Q1
$2.18M Buy
14,200
+8,600
+154% +$1.31M ﹤0.01% 5126
2023
Q4
$885K Sell
5,600
-1,900
-25% -$273K ﹤0.01% 7288
2023
Q3
$1.1M Sell
7,500
-2,100
-22% -$320K ﹤0.01% 6427
2023
Q2
$1.47M Buy
9,600
+4,300
+81% +$671K ﹤0.01% 5811
2023
Q1
$822K Buy
5,300
+2,500
+89% +$393K ﹤0.01% 7343
2022
Q4
$432K Sell
2,800
-5,600
-67% -$826K ﹤0.01% 8250
2022
Q3
$1.11M Sell
8,400
-4,500
-35% -$631K ﹤0.01% 6366
2022
Q2
$1.75M Buy
12,900
+5,100
+65% +$703K ﹤0.01% 5198
2022
Q1
$1.16M Buy
7,800
+5,800
+290% +$858K ﹤0.01% 6743
2021
Q4
$324K Sell
2,000
-6,400
-76% -$1.03M ﹤0.01% 10290
2021
Q3
$1.4M Buy
8,400
+2,000
+31% +$342K ﹤0.01% 6673
2021
Q2
$1.1M Buy
6,400
+2,900
+83% +$479K ﹤0.01% 7493
2021
Q1
$562K Buy
3,500
+400
+13% +$68.5K ﹤0.01% 9211
2020
Q4
$521K Sell
3,100
-1,700
-35% -$276K ﹤0.01% 8195
2020
Q3
$755K Sell
4,800
-9,200
-66% -$1.5M ﹤0.01% 6790
2020
Q2
$2.35M Buy
14,000
+10,400
+289% +$1.63M ﹤0.01% 4203
2020
Q1
$472K Sell
3,600
-6,500
-64% -$926K ﹤0.01% 7070
2019
Q4
$1.5M Buy
10,100
+1,900
+23% +$261K ﹤0.01% 4799
2019
Q3
$1.01M Sell
8,200
-4,800
-37% -$639K ﹤0.01% 5648
2019
Q2
$1.83M Buy
13,000
+5,100
+65% +$704K ﹤0.01% 4354
2019
Q1
$1.19M Buy
7,900
+3,200
+68% +$461K ﹤0.01% 4683
2018
Q4
$584K Sell
4,700
-5,300
-53% -$725K ﹤0.01% 5732
2018
Q3
$1.58M Sell
10,000
-7,700
-44% -$1.17M ﹤0.01% 4381
2018
Q2
$2.48M Sell
17,700
-10,500
-37% -$1.44M ﹤0.01% 3671
2018
Q1
$3.75M Buy
28,200
+9,000
+47% +$1.23M ﹤0.01% 2914
2017
Q4
$2.39M Buy
19,200
+6,800
+55% +$840K ﹤0.01% 3596
2017
Q3
$1.54M Buy
12,400
+3,400
+38% +$402K ﹤0.01% 4409
2017
Q2
$1.03M Sell
9,000
-200
-2% -$21.5K ﹤0.01% 5206
2017
Q1
$969K Buy
9,200
+3,500
+61% +$351K ﹤0.01% 5203
2016
Q4
$518K Sell
5,700
-11,900
-68% -$1.11M ﹤0.01% 6910
2016
Q3
$1.75M Buy
17,600
+1,800
+11% +$177K ﹤0.01% 3772
2016
Q2
$1.41M Buy
15,800
+5,800
+58% +$533K ﹤0.01% 4174
2016
Q1
$876K Sell
10,000
-48,300
-83% -$4.25M ﹤0.01% 5361
2015
Q4
$6.59M Sell
58,300
-5,600
-9% -$603K ﹤0.01% 2192
2015
Q3
$6.47M Buy
63,900
+29,900
+88% +$3.56M ﹤0.01% 2317
2015
Q2
$4.22M Buy
34,000
+4,300
+14% +$519K ﹤0.01% 3196
2015
Q1
$3.51M Buy
29,700
+24,900
+519% +$2.82M ﹤0.01% 3275
2014
Q4
$490K Buy
4,800
+2,200
+85% +$215K ﹤0.01% 7243
2014
Q3
$239K Sell
2,600
-14,600
-85% -$1.27M ﹤0.01% 8368
2014
Q2
$1.42M Sell
17,200
-4,200
-20% -$321K ﹤0.01% 5349
2014
Q1
$1.64M Buy
21,400
+13,700
+178% +$1.07M ﹤0.01% 4657
2013
Q4
$533K Sell
7,700
-7,300
-49% -$479K ﹤0.01% 6589
2013
Q3
$972K Buy
15,000
+900
+6% +$56.9K ﹤0.01% 5318
2013
Q2
$820K Buy
+14,100
New +$805K ﹤0.01% 5316

Other funds holding FBT

Susquehanna International Group's FBT Position: Q1 2026 in Review

Susquehanna International Group increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 101% in Q1 2026, buying an estimated $3.35M and bringing the position to 32,212 shares worth $6.47M. The position accounts for ﹤0.01% of the portfolio, ranked #3812.

Susquehanna International Group first reported a position in FBT in Q2 2013 and has held it in 46 quarters since. The position peaked at $25.6M in Q2 2013. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Susquehanna International Group held 32,212 shares of First Trust NYSE Arca Biotechnology Index Fund worth $6.47M as of Q1 2026.
  • Susquehanna International Group bought 16,203 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $3.35M.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3812 holding.
  • Susquehanna International Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 46 quarters since.
  • Susquehanna International Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $25.6M in Q2 2013.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.